SCHEMBL314135

SCHEMBL314135

COc1ccc2c(c1)NC[C@@H](C)c1nnc(-c3cccc(Cl)c3)n1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
TP53 P04637 1/20 0.39
GLA P06280 1/20 0.38
CNR1 P21554 1/20 0.35
BRD4 O60885 3/20 0.34
PIM1 P11309 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CTSD P07339 1/20 0.34
BACE1 P56817 1/20 0.34
LRRK2 Q5S007 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314136 1.00 ALDH1A1 (0.40) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL314534 1.00 ALDH1A1 (0.40) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL314088 0.92 ALDH1A1 (0.45) ALDH1A1MAPK14GLACNR1PIM1
SCHEMBL314086 0.92 ALDH1A1 (0.45) ALDH1A1MAPK14GLACNR1PIM1
SCHEMBL314087 0.92 ALDH1A1 (0.45) ALDH1A1MAPK14GLACNR1PIM1
SCHEMBL313881 0.92 ALDH1A1 (0.40) ALDH1A1TP53PIM1GAAMAPT
SCHEMBL313882 0.92 ALDH1A1 (0.40) ALDH1A1TP53PIM1GAAMAPT
SCHEMBL313880 0.92 ALDH1A1 (0.40) ALDH1A1TP53PIM1GAAMAPT
SCHEMBL315182 0.90 TP53 (0.43) ALDH1A1TP53CNR1BRD4POLB
SCHEMBL315184 0.90 TP53 (0.43) ALDH1A1TP53CNR1BRD4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US claimed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP claimed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US claimed
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US disclosed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP disclosed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306042-A1 Triazole Derivatives TGFBR1, TGFBR2, SMAD3 ALDH1A1 2295/4885MAPK13 823/4885MAPK12 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.